EssilorLuxottica Board of Directors to Propose Reappointment of 8 Directors; Group Launches Share Buyback Plan

Published on February 17, 2026
PARIS—The EssilorLuxottica (Reuters: ESLX.PA) board of directors announced it intends to propose the reappointment of the eight directors whose terms are expiring at the shareholders’ meeting set for April 28, 2026. To continue implementing the staggering of the directors’ terms of office approved by shareholders at the 2024 general meeting, the board has proposed the following appointments: Romolo Bardin, José Gonzalo, Virginie Mercier-Pitre, and Swati Piramal are each proposed for an additional three-year term, while Mario Notari, Cristina Scocchia, Nathalie von Siemens, and Andrea Zappia are proposed for an additional two-year term, the announcement said.
Continue reading on website
Other news

Topical Insulin Effective Against Neurotrophic Keratopathy, Study Finds

February 17, 2026
A total of 23 eyes with Stage 2 or 3 neurotrophic keratopathy were treated with insulin and 18 completely healed during the trial, but five eyes failed to achieve the primary outcome. Instead, three of the remaining eyes progressed in ulcer size, one remained unchanged and the final subject improved but did not heal completely. Of the three progressive ulcer cases, two underwent tarsorrhaphy to re

Thélios to Host Dual-Location Experience for NYC Eyewear Design Week

February 17, 2026
NEW YORK—Thélios, the eyewear segment of the LVMH Group, has announced that it will present a dual-location experience during Eyewear Design Week NYC 2026, showcasing the Summer 2026 eyewear collections across its luxury portfolio. The presentations reflect both new creative leadership at Thélios’ Maisons and the continued evolution of Maisons’ established codes, Thélios said in the announcement.